Molecules

Articles

• acetyl-CoA
  2 June 2004

  Acetyl CoA

• dopamine
  9 May 2005

  References
  Lotharius J, Brundin P. Pathogenesis of Parkinson’s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci. 2002 Dec;3(12):932-42. PMID: #12461550

• estrogens
  15 April 2005

  Estrogens are key regulators of growth, differentiation, and the physiological functions of a wide range of target tissues, including the male and female reproductive tracts, breast, and skeletal, nervous, cardiovascular, digestive and immune systems.
  The majority of these biological activities of estrogens are mediated through two genetically distinct receptors, ERalpha and ERbeta, which function as hormone-inducible transcription factors.
  Over the past decade, it has become increasingly (...)

• hydrogen peroxide
  6 January 2008

  H2O2

• uracil
  17 October 2005

  Definition: Uracil is a pyrimidine base (nitrogenous base) and constituent of nucleotides and as such one member of the base pair A-U (adenine-uracil). It is normally found in RNA but not DNA.
  Uracil is one of the four major RNA nucleobases, and replaces the DNA base thymine. Similar to thymine, uracil can form a base pair with adenine via two hydrogen bonds, but it lacks the methyl group present in thymine.
  Uracil is not normally incorporated into DNA and is only very rarely observed in (...)

• HDL
  12 June 2005

  high-density lipoprotein

• histamine
  12 June 2005

  Histamine is a vasocative amine widely distributed in tissues.
  Histamine is found the mast cells (masotcytes), in blood basophils and in platelets.
  Preformed histamine is present in mast cell granules and is released by mast cell degranulation in response to a variety of stimuli: (1) physical injury such as trauma, cold, or heat; (2) immune reactions involving binding of antibodies to mast cells (Chapter 6); (3) fragments of complement called anaphylatoxins (C3a and C5a); (4) (...)

• H2O2
  12 February 2006

  H(2)O(2)

• PIP2
  12 February 2006

  phosphoinositol-diphosphate

• MORF-CBP
  9 June 2003

  Pathology:
  Fusion gene formation in MORF-CBP in acute myeloid leukemia with the t(10;16)(q22;p13) (#11157802#)

0 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90